"Material Time, Material Extent" Proposed Rule Issued By FDA
This article was originally published in The Rose Sheet
Executive Summary
The safety profile of foreign OTC drugs requiring pharmacist intervention will be the deciding factor in an FDA decision to include drug ingredients sold outside the U.S. in an OTC drug monograph.
You may also be interested in...
OTC “Time & Extent” Requirements Reduced For Extensively Marketed Drugs
Sponsors of OTC drugs with extensive foreign marketing experience need not provide detailed information from each country in requesting the drug or "condition" be considered for OTC monograph eligibility in the U.S., FDA says
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program